Newsfeeds - Spark Newswire

1 minute read

Maxim Group Initiates Coverage On ATAI Life Sciences with Buy Rating, Announces Price Target of $25

Today, 6:59 PM

Maxim Group analyst Michael Okunewitch initiates coverage on ATAI Life Sciences (NASDAQ:ATAI) with a Buy rating and announces Price Target of $25.

ATAI

3 minute read

Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways

By David Carpenter

Today, 6:59 PM

Biopharmaceutical conglomerate ATAI Life Sciences (NASDAQ: ATAI), a Peter Thiel-backed psychedelic startup that currently has 10 psychedelic programs in the works, has upped its stake in Compass Pat

ATAI

1 minute read

HC Wainwright & Co. Maintains Buy on ATAI Life Sciences, Raises Price Target to $50

By Benzinga Newsdesk

Today, 6:59 PM

HC Wainwright & Co. analyst Patrick Trucchio maintains ATAI Life Sciences (NASDAQ:ATAI) with a Buy and raises the price target from $40 to $50.

ATAI

1 minute read

RBC Capital Maintains Sector Perform on ATAI Life Sciences, Lowers Price Target to $17

By Benzinga Newsdesk

Today, 6:59 PM

RBC Capital analyst Brian Abrahams maintains ATAI Life Sciences (NASDAQ:ATAI) with a Sector Perform and lowers the price target from $19 to $17.

ATAI

2 minute read

Analyst Ratings

Analyst Ratings For ATAI Life Sciences

By Benzinga Insights

Today, 6:59 PM

Analysts have provided the following ratings for ATAI Life Sciences (NASDAQ:ATAI) within the last quarter:

ATAI

1 minute read

Roth Capital Initiates Coverage On ATAI Life Sciences with Buy Rating, Announces Price Target of $32

By Benzinga Newsdesk

Today, 6:59 PM

Roth Capital analyst Elemer Piros initiates coverage on ATAI Life Sciences (NASDAQ:ATAI) with a Buy rating and announces Price Target of $32.

ATAI

1 minute read

ATAI Life’s Schizophrenia Candidate Shows Promising Action In Mid-Stage Study

By Vandana Singh

Today, 6:59 PM

ATAI Life Sciences NV (NASDAQ:ATAI) announced interim data from the first 8-patient cohort of its Phase 2a trial of RL-007 for…

ATAI

5 minute read

Psyched: The 50 Publicly-listed Psychedelics Companies, Atai’s New Subsidiary, PharmaTher Gets New Orphan Drug Designation

By Natan Ponieman

Today, 6:59 PM

The Week In Psychedelics

AGNPF

27 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 18, 2021

By Benzinga Insights

Today, 6:59 PM

Upgrades

AGRO

2 minute read

There Are Now 50 Psychedelics Companies Listed In The U.S. – Here They Are

By Natan Ponieman

Today, 6:59 PM

Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.

AGNPF